Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
VIR
Home
/
VIR

NASDAQ
$11.6009
$11.6009

Overview

Price performance
Low
$11.17
High
$11.80
Market open. Last updated: Nov 4, 2026, 8:07 PM UTC
$
11.60
0.38 (3.39%)
Average, 50 days
$10.99
$9.57
Open
$11.68
Previous close
$11.22
52-week high
$12.19
Oct 29, 2026 (7 days ago)
52-week low
$4.82
Nov 7, 2025 (13 months ago)
140.68%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
1.96B
Volume
1 346 590
Total Return (3M)
26.72%
Total Return (1Y)
121.34%
—
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
vir.bio
About
Vir Biotechnology, Inc. operates as an immunology company with commercialized products, dedicated to devising therapeutic solutions for the treatment and prevention of significant infectious diseases. Its pipeline features several key candidates: Sotrovimab (branded as Xevudy, or VIR-7832), a neutralizing monoclonal antibody for both treating and preventing SARS-CoV-2 infection; VIR-2218 and VIR-3434, aimed at hepatitis B virus; VIR-2482, targeting the prevention of influenza A virus; and VIR-1111, designed to prevent human immunodeficiency virus. The firm maintains a robust network of strategic partnerships and collaborations. These include grant support from organizations like the Bill & Melinda Gates Foundation and the National Institutes of Health. It holds option and licensing arrangements with entities such as Brii Biosciences Limited, and a collaboration and license agreement with Alnylam Pharmaceuticals, Inc. Further licensing relationships exist with The Rockefeller University and MedImmune, Inc. Collaborations extend to WuXi Biologics and Glaxo Wellcome UK Ltd., alongside a research agreement with GlaxoSmithKline Biologicals SA. Furthermore, Vir has secured a manufacturing contract with Samsung Biologics Co.,Ltd. for SARS-CoV-2 antibodies and a clinical development partnership with Gilead Sciences, Inc. focused on chronic hepatitis B virus. The company, established in 2016, is headquartered in San Francisco, California.

Frequently asked questions

VIR · Vir Biotechnology, Inc.

01What is Vir Biotechnology, Inc. stock price today?

The current price of VIR is $11.60 — it has increased by 3.39% since the previous close. Data as of Nov 4, 2026.

02Is Vir Biotechnology, Inc. stock price growing?

VIR is down 0.08% over the past week, up 4.03% over the past month and up 121.34% over the past year. The price is above its 200-day moving average of $9.57.

03What is Vir Biotechnology, Inc. market cap?

Vir Biotechnology, Inc. has a market capitalization of $1.96B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

04How volatile is VIR stock?

In the latest trading session VIR moved between $11.17 and $11.81, a range of 5.47% of its current price.

05What are VIR stock 52-week high and low?

Over the past 52 weeks VIR has traded between $4.82 and $12.19. The current price is 4.83% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.